No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Times cited: 5
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.
JAMA - Journal of the American Medical Association.
Times cited: 170
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk.
Times cited: 167